Alto Neuroscience Stock Market Value
| ANRO Stock | 16.89 0.45 2.74% |
| Symbol | Alto |
Will Pharmaceuticals sector continue expanding? Could Alto diversify its offerings? Factors like these will boost the valuation of Alto Neuroscience. If investors know Alto will grow in the future, the company's valuation will be higher. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Alto Neuroscience data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Understanding Alto Neuroscience requires distinguishing between market price and book value, where the latter reflects Alto's accounting equity. The concept of intrinsic value - what Alto Neuroscience's is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Market sentiment, economic cycles, and investor behavior can push Alto Neuroscience's price substantially above or below its fundamental value.
Understanding that Alto Neuroscience's value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Alto Neuroscience represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. In contrast, Alto Neuroscience's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.
Alto Neuroscience 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Alto Neuroscience's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Alto Neuroscience.
| 11/17/2025 |
| 02/15/2026 |
If you would invest 0.00 in Alto Neuroscience on November 17, 2025 and sell it all today you would earn a total of 0.00 from holding Alto Neuroscience or generate 0.0% return on investment in Alto Neuroscience over 90 days. Alto Neuroscience is related to or competes with Cellectis, AC Immune, Amarin PLC, Larimar Therapeutics, Contineum Therapeutics, Aldeyra, and Alpha Tau. Alto Neuroscience is entity of United States More
Alto Neuroscience Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Alto Neuroscience's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Alto Neuroscience upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 6.21 | |||
| Information Ratio | 0.0928 | |||
| Maximum Drawdown | 26.04 | |||
| Value At Risk | (8.77) | |||
| Potential Upside | 7.87 |
Alto Neuroscience Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Alto Neuroscience's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Alto Neuroscience's standard deviation. In reality, there are many statistical measures that can use Alto Neuroscience historical prices to predict the future Alto Neuroscience's volatility.| Risk Adjusted Performance | 0.0937 | |||
| Jensen Alpha | 0.5127 | |||
| Total Risk Alpha | 0.1619 | |||
| Sortino Ratio | 0.0822 | |||
| Treynor Ratio | 0.5883 |
Alto Neuroscience February 15, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0937 | |||
| Market Risk Adjusted Performance | 0.5983 | |||
| Mean Deviation | 3.92 | |||
| Semi Deviation | 5.44 | |||
| Downside Deviation | 6.21 | |||
| Coefficient Of Variation | 947.94 | |||
| Standard Deviation | 5.51 | |||
| Variance | 30.32 | |||
| Information Ratio | 0.0928 | |||
| Jensen Alpha | 0.5127 | |||
| Total Risk Alpha | 0.1619 | |||
| Sortino Ratio | 0.0822 | |||
| Treynor Ratio | 0.5883 | |||
| Maximum Drawdown | 26.04 | |||
| Value At Risk | (8.77) | |||
| Potential Upside | 7.87 | |||
| Downside Variance | 38.61 | |||
| Semi Variance | 29.59 | |||
| Expected Short fall | (3.86) | |||
| Skewness | (0.60) | |||
| Kurtosis | 2.37 |
Alto Neuroscience Backtested Returns
Alto Neuroscience appears to be not too volatile, given 3 months investment horizon. Alto Neuroscience secures Sharpe Ratio (or Efficiency) of 0.0938, which signifies that the company had a 0.0938 % return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for Alto Neuroscience, which you can use to evaluate the volatility of the firm. Please makes use of Alto Neuroscience's Risk Adjusted Performance of 0.0937, downside deviation of 6.21, and Mean Deviation of 3.92 to double-check if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Alto Neuroscience holds a performance score of 7. The firm shows a Beta (market volatility) of 0.97, which signifies possible diversification benefits within a given portfolio. Alto Neuroscience returns are very sensitive to returns on the market. As the market goes up or down, Alto Neuroscience is expected to follow. Please check Alto Neuroscience's value at risk, as well as the relationship between the skewness and day median price , to make a quick decision on whether Alto Neuroscience's price patterns will revert.
Auto-correlation | -0.45 |
Modest reverse predictability
Alto Neuroscience has modest reverse predictability. Overlapping area represents the amount of predictability between Alto Neuroscience time series from 17th of November 2025 to 1st of January 2026 and 1st of January 2026 to 15th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Alto Neuroscience price movement. The serial correlation of -0.45 indicates that just about 45.0% of current Alto Neuroscience price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.45 | |
| Spearman Rank Test | 0.01 | |
| Residual Average | 0.0 | |
| Price Variance | 0.65 |
Pair Trading with Alto Neuroscience
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Alto Neuroscience position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Alto Neuroscience will appreciate offsetting losses from the drop in the long position's value.Moving against Alto Stock
| 0.71 | KG | Kestrel Group Symbol Change | PairCorr |
| 0.46 | HCM | HUTCHMED China | PairCorr |
| 0.43 | ELTX | Elicio Therapeutics | PairCorr |
| 0.38 | BSFA | ANI Pharmaceuticals | PairCorr |
| 0.36 | IQ70 | 1CM INC | PairCorr |
The ability to find closely correlated positions to Alto Neuroscience could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Alto Neuroscience when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Alto Neuroscience - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Alto Neuroscience to buy it.
The correlation of Alto Neuroscience is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Alto Neuroscience moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Alto Neuroscience moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Alto Neuroscience can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Alto Neuroscience Correlation, Alto Neuroscience Volatility and Alto Neuroscience Performance module to complement your research on Alto Neuroscience. To learn how to invest in Alto Stock, please use our How to Invest in Alto Neuroscience guide.You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.
Alto Neuroscience technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.